Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator.
Weygand J, Armstrong T, Bryant JM, Andreozzi JM, Oraiqat IM, Nichols S, Liveringhouse CL, Latifi K, Yamoah K, Costello JR, Frakes JM, Moros EG, El Naqa IM, Naghavi AO, Rosenberg SA, Redler G. Weygand J, et al. Among authors: bryant jm. Phys Imaging Radiat Oncol. 2023 Nov 8;28:100505. doi: 10.1016/j.phro.2023.100505. eCollection 2023 Oct. Phys Imaging Radiat Oncol. 2023. PMID: 38045642 Free PMC article.
Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART).
Bryant JM, Palm RF, Liveringhouse C, Boyer E, Hodul P, Malafa M, Denbo J, Kim D, Carballido E, Fleming JB, Hoffe S, Frakes J. Bryant JM, et al. Adv Radiat Oncol. 2022 Aug 6;7(6):101045. doi: 10.1016/j.adro.2022.101045. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420193 Free PMC article.
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART).
Bryant JM, Palm RF, Herrera R, Rubens M, Hoffe SE, Kim DW, Kaiser A, Ucar A, Fleming J, De Zarraga F, Hodul P, Aparo S, Asbun H, Malafa M, Jimenez R, Denbo J, Frakes JM, Chuong MD. Bryant JM, et al. Cancer Control. 2023 Jan-Dec;30:10732748221150228. doi: 10.1177/10732748221150228. Cancer Control. 2023. PMID: 36598464 Free PMC article.
Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma.
Liveringhouse CL, Palm RF, Bryant JM, Yang GQ, Mills MN, Figura ND, Ahmed KA, Mullinax J, Gonzalez R, Johnstone PA, Naghavi AO. Liveringhouse CL, et al. Among authors: bryant jm. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):123-138. doi: 10.1016/j.ijrobp.2023.03.037. Epub 2023 Mar 18. Int J Radiat Oncol Biol Phys. 2023. PMID: 36935026 Clinical Trial.
Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions.
Sandoval ML, Sim AJ, Bryant JM, Bhandari M, Wuthrick EJ, Perez BA, Dilling TJ, Redler G, Andreozzi J, Nardella L, Feygelman V, Latifi K, Rosenberg SA. Sandoval ML, et al. Among authors: bryant jm. JTO Clin Res Rep. 2023 Feb 25;4(5):100488. doi: 10.1016/j.jtocrr.2023.100488. eCollection 2023 May. JTO Clin Res Rep. 2023. PMID: 37159821 Free PMC article.
Trimodal Therapy Using an MR-guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer.
Liveringhouse C, Netzley A, Bryant JM, Linkowski LC, Weygand J, Sandoval ML, Dohm A, Dookhoo M, Kelley S, Rosenberg SA, Latifi K, Torres-Roca JF, Johnstone PAS, Yamoah K, Grass GD. Liveringhouse C, et al. Among authors: bryant jm. Adv Radiat Oncol. 2023 May 18;8(6):101268. doi: 10.1016/j.adro.2023.101268. eCollection 2023 Nov-Dec. Adv Radiat Oncol. 2023. PMID: 38047218 Free PMC article.
114 results